Chong Kun Dang held the 8th regular shareholders’ meeting at the headquarters of Chong Kun Dang in Chungjeong-ro on the 26th.
Chong Kun Dang reported at the general shareholders’ meeting that it achieved consolidated sales of KRW 1.30.3 trillion and operating profit of KRW 123.9 billion in 2020, and decided to pay a cash dividend of KRW 1,000 per share, which is 40% of the face value.
CEO Kim Young-joo said in his greeting, “Last year, the domestic economy recorded negative growth due to the global economic downturn. Despite difficult economic conditions and external variables, we recorded the highest sales and operating profit.”
Regarding this year’s plan, CEO Kim said, “We will pursue qualitative growth by preparing a substantial growth structure, and we will achieve continuous growth based on differentiated competitiveness amid uncertainties through entry into overseas markets and strengthening R&D pipelines.”
Chong Kun Dang Holdings also held the 66th regular shareholders’ meeting on the same day. Chong Kun Dang Holdings reported consolidated sales of KRW 858.1 billion and operating profit of KRW 89.3 billion in 2020, and decided to implement a cash dividend of KRW 1,400 per share, which is 56% of the face value.
▲ Chong Kun Dang
Re-appointment of internal director: Kim Young-joo (CEO Jong Geun-dang)
Seong-Gon Kim (Director of Hyojong Research Institute, Jong Geun-dang)
Jamin Koo (Chong Kun Dang Business Planning Manager)
▲ Chong Kun Dang Holdings
New internal director appointment: Taeyoung Kim (CEO of Kyungbo Pharmaceutical)
Reappointment of internal director: Jang-Won Choi (Director of Human Resources Development/Social Contribution, Jong Kun Dang Holdings)
Newly appointed full-time auditor: Jo Jung-yong (Head of Investment Management Division, Morgan Stanley Securities Seoul Branch)